Copyright Reports & Markets. All rights reserved.

Covid-19 Impact on Bulk Drug Market, Global Research Reports 2020-2021

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Bulk Drug Industry
  • 1.7 COVID-19 Impact: Bulk Drug Market Trends

    • 2 Global Bulk Drug Quarterly Market Size Analysis

    • 2.1 Bulk Drug Business Impact Assessment - COVID-19
      • 2.1.1 Global Bulk Drug Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global Bulk Drug Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Bulk Drug Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global Bulk Drug Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global Bulk Drug Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers Bulk Drug Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into Bulk Drug Market
    • 3.5 Key Manufacturers Bulk Drug Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Bulk Drug Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Antibiotics
      • 1.4.2 Sulpha Drugs
      • 1.4.3 Vitamins,
      • 1.4.4 Steroids
      • 1.4.5 Analgesics
      • 1.4.6 Others
    • 4.2 By Type, Global Bulk Drug Market Size, 2019-2021
      • 4.2.1 By Type, Global Bulk Drug Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global Bulk Drug Price, 2020-2021

    5 Impact of Covid-19 on Bulk Drug Segments, By Application

    • 5.1 Overview
      • 5.5.1 Hospitals
      • 5.5.2 Clinics
      • 5.5.3 Others
    • 5.2 By Application, Global Bulk Drug Market Size, 2019-2021
      • 5.2.1 By Application, Global Bulk Drug Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global Bulk Drug Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Teva
      • 7.1.1 Teva Business Overview
      • 7.1.2 Teva Bulk Drug Quarterly Production and Revenue, 2020
      • 7.1.3 Teva Bulk Drug Product Introduction
      • 7.1.4 Teva Response to COVID-19 and Related Developments
    • 7.2 Novartis
      • 7.2.1 Novartis Business Overview
      • 7.2.2 Novartis Bulk Drug Quarterly Production and Revenue, 2020
      • 7.2.3 Novartis Bulk Drug Product Introduction
      • 7.2.4 Novartis Response to COVID-19 and Related Developments
    • 7.3 Pfizer
      • 7.3.1 Pfizer Business Overview
      • 7.3.2 Pfizer Bulk Drug Quarterly Production and Revenue, 2020
      • 7.3.3 Pfizer Bulk Drug Product Introduction
      • 7.3.4 Pfizer Response to COVID-19 and Related Developments
    • 7.4 Johnson & Johnson
      • 7.4.1 Johnson & Johnson Business Overview
      • 7.4.2 Johnson & Johnson Bulk Drug Quarterly Production and Revenue, 2020
      • 7.4.3 Johnson & Johnson Bulk Drug Product Introduction
      • 7.4.4 Johnson & Johnson Response to COVID-19 and Related Developments
    • 7.5 Mylan
      • 7.5.1 Mylan Business Overview
      • 7.5.2 Mylan Bulk Drug Quarterly Production and Revenue, 2020
      • 7.5.3 Mylan Bulk Drug Product Introduction
      • 7.5.4 Mylan Response to COVID-19 and Related Developments
    • 7.6 North China Pharmaceutical Group
      • 7.6.1 North China Pharmaceutical Group Business Overview
      • 7.6.2 North China Pharmaceutical Group Bulk Drug Quarterly Production and Revenue, 2020
      • 7.6.3 North China Pharmaceutical Group Bulk Drug Product Introduction
      • 7.6.4 North China Pharmaceutical Group Response to COVID-19 and Related Developments
    • 7.7 Dr. Reddy’s Laboratories
      • 7.7.1 Dr. Reddy’s Laboratories Business Overview
      • 7.7.2 Dr. Reddy’s Laboratories Bulk Drug Quarterly Production and Revenue, 2020
      • 7.7.3 Dr. Reddy’s Laboratories Bulk Drug Product Introduction
      • 7.7.4 Dr. Reddy’s Laboratories Response to COVID-19 and Related Developments
    • 7.8 Roche
      • 7.8.1 Roche Business Overview
      • 7.8.2 Roche Bulk Drug Quarterly Production and Revenue, 2020
      • 7.8.3 Roche Bulk Drug Product Introduction
      • 7.8.4 Roche Response to COVID-19 and Related Developments
    • 7.9 Aurobindo pharma
      • 7.9.1 Aurobindo pharma Business Overview
      • 7.9.2 Aurobindo pharma Bulk Drug Quarterly Production and Revenue, 2020
      • 7.9.3 Aurobindo pharma Bulk Drug Product Introduction
      • 7.9.4 Aurobindo pharma Response to COVID-19 and Related Developments
    • 7.10 Sun Pharmaceutical Industries
      • 7.10.1 Sun Pharmaceutical Industries Business Overview
      • 7.10.2 Sun Pharmaceutical Industries Bulk Drug Quarterly Production and Revenue, 2020
      • 7.10.3 Sun Pharmaceutical Industries Bulk Drug Product Introduction
      • 7.10.4 Sun Pharmaceutical Industries Response to COVID-19 and Related Developments
    • 7.11 Boehringer Ingelheim GmbH
      • 7.11.1 Boehringer Ingelheim GmbH Business Overview
      • 7.11.2 Boehringer Ingelheim GmbH Bulk Drug Quarterly Production and Revenue, 2020
      • 7.11.3 Boehringer Ingelheim GmbH Bulk Drug Product Introduction
      • 7.11.4 Boehringer Ingelheim GmbH Response to COVID-19 and Related Developments
    • 7.12 Bayer
      • 7.12.1 Bayer Business Overview
      • 7.12.2 Bayer Bulk Drug Quarterly Production and Revenue, 2020
      • 7.12.3 Bayer Bulk Drug Product Introduction
      • 7.12.4 Bayer Response to COVID-19 and Related Developments
    • 7.13 BASF
      • 7.13.1 BASF Business Overview
      • 7.13.2 BASF Bulk Drug Quarterly Production and Revenue, 2020
      • 7.13.3 BASF Bulk Drug Product Introduction
      • 7.13.4 BASF Response to COVID-19 and Related Developments
    • 7.14 DSM
      • 7.14.1 DSM Business Overview
      • 7.14.2 DSM Bulk Drug Quarterly Production and Revenue, 2020
      • 7.14.3 DSM Bulk Drug Product Introduction
      • 7.14.4 DSM Response to COVID-19 and Related Developments
    • 7.15 Zhejiang Medicine
      • 7.15.1 Zhejiang Medicine Business Overview
      • 7.15.2 Zhejiang Medicine Bulk Drug Quarterly Production and Revenue, 2020
      • 7.15.3 Zhejiang Medicine Bulk Drug Product Introduction
      • 7.15.4 Zhejiang Medicine Response to COVID-19 and Related Developments
    • 7.16 Biocon
      • 7.16.1 Biocon Business Overview
      • 7.16.2 Biocon Bulk Drug Quarterly Production and Revenue, 2020
      • 7.16.3 Biocon Bulk Drug Product Introduction
      • 7.16.4 Biocon Response to COVID-19 and Related Developments
    • 7.17 Johnson Matthey
      • 7.17.1 Johnson Matthey Business Overview
      • 7.17.2 Johnson Matthey Bulk Drug Quarterly Production and Revenue, 2020
      • 7.17.3 Johnson Matthey Bulk Drug Product Introduction
      • 7.17.4 Johnson Matthey Response to COVID-19 and Related Developments
    • 7.18 Hisun Pharmacy
      • 7.18.1 Hisun Pharmacy Business Overview
      • 7.18.2 Hisun Pharmacy Bulk Drug Quarterly Production and Revenue, 2020
      • 7.18.3 Hisun Pharmacy Bulk Drug Product Introduction
      • 7.18.4 Hisun Pharmacy Response to COVID-19 and Related Developments
    • 7.19 Cambrex
      • 7.19.1 Cambrex Business Overview
      • 7.19.2 Cambrex Bulk Drug Quarterly Production and Revenue, 2020
      • 7.19.3 Cambrex Bulk Drug Product Introduction
      • 7.19.4 Cambrex Response to COVID-19 and Related Developments
    • 7.20 Shandong Xinhua Pharmaceutical
      • 7.20.1 Shandong Xinhua Pharmaceutical Business Overview
      • 7.20.2 Shandong Xinhua Pharmaceutical Bulk Drug Quarterly Production and Revenue, 2020
      • 7.20.3 Shandong Xinhua Pharmaceutical Bulk Drug Product Introduction
      • 7.20.4 Shandong Xinhua Pharmaceutical Response to COVID-19 and Related Developments
    • 7.21 Lonza group
      • 7.21.1 Lonza group Business Overview
      • 7.21.2 Lonza group Bulk Drug Quarterly Production and Revenue, 2020
      • 7.21.3 Lonza group Bulk Drug Product Introduction
      • 7.21.4 Lonza group Response to COVID-19 and Related Developments
    • 7.22 Huahai Pharmaceutical
      • 7.22.1 Huahai Pharmaceutical Business Overview
      • 7.22.2 Huahai Pharmaceutical Bulk Drug Quarterly Production and Revenue, 2020
      • 7.22.3 Huahai Pharmaceutical Bulk Drug Product Introduction
      • 7.22.4 Huahai Pharmaceutical Response to COVID-19 and Related Developments
    • 7.23 Haerbin Pharmaceutical Group
      • 7.23.1 Haerbin Pharmaceutical Group Business Overview
      • 7.23.2 Haerbin Pharmaceutical Group Bulk Drug Quarterly Production and Revenue, 2020
      • 7.23.3 Haerbin Pharmaceutical Group Bulk Drug Product Introduction
      • 7.23.4 Haerbin Pharmaceutical Group Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 Bulk Drug Supply Chain Analysis
      • 8.1.1 Bulk Drug Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on Bulk Drug Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 Bulk Drug Distribution Channels
      • 8.2.2 Covid-19 Impact on Bulk Drug Distribution Channels
      • 8.2.3 Bulk Drug Distributors
    • 8.3 Bulk Drug Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of Bulk Drug, including the following market information:
      Global Bulk Drug Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
      Global Bulk Drug Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
      Global Bulk Drug Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
      Global Bulk Drug Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K MT)

      Key market players
      Major competitors identified in this market include Teva, Novartis, Pfizer, Johnson & Johnson, Mylan, North China Pharmaceutical Group, Dr. Reddy’s Laboratories, Roche, Aurobindo pharma, Sun Pharmaceutical Industries, Boehringer Ingelheim GmbH, Bayer, BASF, DSM, Zhejiang Medicine, Biocon, Johnson Matthey, Hisun Pharmacy, Cambrex, Shandong Xinhua Pharmaceutical, Lonza group, Huahai Pharmaceutical, Haerbin Pharmaceutical Group, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Antibiotics
      Sulpha Drugs
      Vitamins,
      Steroids
      Analgesics
      Others

      Based on the Application:
      Hospitals
      Clinics
      Others

      Buy now